Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 359

1.

Point-of-care Ultrasound Diagnosis of Type B Aortic Dissection on the Suprasternal Notch View.

Wang RN, Escobar M, North S, Lin J.

Cureus. 2019 Oct 27;11(10):e6005. doi: 10.7759/cureus.6005.

2.

The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.

Meyers DE, Stukalin I, Vallerand IA, Lewinson RT, Suo A, Dean M, North S, Pabani A, Cheng T, Heng DYC, Bebb DG, Morris DG.

Cancers (Basel). 2019 Nov 2;11(11). pii: E1713. doi: 10.3390/cancers11111713.

3.

The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy.

Black AJ, Zargar H, Zargar-Shoshtari K, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Griffin J, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, McGrath JS, Aning J, Shariat SF, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Spiess PE, Daneshmand S, Sridhar SS, Black PC.

Urol Oncol. 2020 Jan;38(1):3.e17-3.e27. doi: 10.1016/j.urolonc.2019.09.023. Epub 2019 Oct 31.

PMID:
31676278
4.

Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.

Hotte SJ, Kapoor A, Basappa NS, Bjarnason G, Canil C, Conter HJ, Czaykowski P, Graham J, Gray S, Heng DYC, Karakiewicz PI, Kollmannsberger C, Lalani AA, North SA, Patenaude F, Soulières D, Violette P, Winquist E, Wood LA, Dudani S, Maloni R, Reaume MN; Kidney Cancer Research Network of Canada.

Can Urol Assoc J. 2019 Oct;13(10):343-354. doi: 10.5489/cuaj.6256. No abstract available.

5.

2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, So A, Usmani N, Vigneault E, Chi KN.

Can Urol Assoc J. 2019 Oct;13(10):307-314. doi: 10.5489/cuaj.6136. No abstract available.

6.

Humanising medicine: teaching on tri-morbidity using expert patient narratives in medical education.

Player E, Gure-Klinke H, North S, Hanson S, Lane D, Culyer G, Rodrigues V.

Educ Prim Care. 2019 Oct 3:1-7. doi: 10.1080/14739879.2019.1670097. [Epub ahead of print]

PMID:
31580229
7.

Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Graham J, Wells JC, Donskov F, Lee JL, Fraccon A, Pasini F, Porta C, Bowman IA, Bjarnason GA, Ernst DS, Rha SY, Beuselinck B, Hansen A, North SA, Kollmannsberger CK, Wood LA, Vaishampayan UN, Pal SK, Choueiri TK, Heng DYC.

Eur Urol Oncol. 2019 Nov;2(6):643-648. doi: 10.1016/j.euo.2019.03.007. Epub 2019 Apr 5.

PMID:
31411994
8.

Management of urachal cancer: A review by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada.

Hamilou Z, North S, Canil C, Wood L, Hotte S, Sridhar S, Soulières D, Latour M, Taussky D, Kassouf W, Blais N.

Can Urol Assoc J. 2019 Jul 23. doi: 10.5489/cuaj.5946. [Epub ahead of print] Review. No abstract available.

PMID:
31348743
9.

2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guidelines for the management of castration-resistant prostate cancer (CRPC).

Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North S, Pouliot F, Rendon R, Shayegan B, Sridhar S, So A, Usmani N, Vigneault E, Chi KN.

Can Urol Assoc J. 2019 Jun 25. doi: 10.5489/cuaj.6136. [Epub ahead of print] No abstract available.

PMID:
31348741
10.

Toward Optimal Communication About HPV Vaccination for Preteens and Their Parents: Evaluation of an Online Training for Pediatric and Family Medicine Health Care Providers.

Cates JR, Diehl SJ, Fuemmeler BF, North SW, Chung RJ, Hill JF, Coyne-Beasley T.

J Public Health Manag Pract. 2019 Jul 24. doi: 10.1097/PHH.0000000000001022. [Epub ahead of print]

PMID:
31348153
11.

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group.

N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2.

PMID:
31157964
12.

Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae.

North SJ, Botchway K, Doonan J, Lumb FE, Dell A, Harnett W, Haslam SM.

Glycobiology. 2019 Jul 19;29(8):562-571. doi: 10.1093/glycob/cwz035.

13.

Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.

Warren M, Kolinsky M, Canil CM, Czaykowski P, Sridhar SS, Black PC, Booth CM, Kassouf W, Eapen L, Mukherjee SD, Blais N, Eigl BJ, Winquist E, Basappa NS, North SA; GUMOC.

Can Urol Assoc J. 2019 Apr 26:318-327. doi: 10.5489/cuaj.6015. [Epub ahead of print] No abstract available.

14.

A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration-resistant Prostate Cancer: Canadian Cancer Trials Group Study IND205.

Hotte SJ, Chi KN, Joshua AM, Tu D, Macfarlane RJ, Gregg RW, Ruether JD, Basappa NS, Finch D, Salim M, Winquist EW, Torri V, North S, Kollmannsberger C, Ellard SL, Eigl BJ, Tinker A, Allan AL, Beja K, Annala M, Powers J, Wyatt AW, Seymour L; Canadian Cancer Trials Group (formerly NCIC Clinical Trials Group).

Clin Genitourin Cancer. 2019 Jun;17(3):201-208.e1. doi: 10.1016/j.clgc.2019.03.005. Epub 2019 Mar 15.

PMID:
31056399
15.

Temperature perturbation related to the invisible ink vibrationally excited nitric oxide monitoring (VENOM) technique: a simulation study.

Winner JD, Pan F, McIlvoy MH, Bowersox RDW, North SW.

Appl Opt. 2019 Apr 1;58(10):2702-2712. doi: 10.1364/AO.58.002702.

PMID:
31045076
16.

Low-carbohydrate, healthy-fat eating: A cost comparison with national dietary guidelines.

Zinn C, North S, Donovan K, Muir C, Henderson G.

Nutr Diet. 2019 Apr 24. doi: 10.1111/1747-0080.12534. [Epub ahead of print]

PMID:
31020780
17.

Quantitative Analyses Reveal Novel Roles for N-Glycosylation in a Major Enteric Bacterial Pathogen.

Abouelhadid S, North SJ, Hitchen P, Vohra P, Chintoan-Uta C, Stevens M, Dell A, Cuccui J, Wren BW.

MBio. 2019 Apr 23;10(2). pii: e00297-19. doi: 10.1128/mBio.00297-19.

18.

Anomalous Intensities in the 2+1 REMPI Spectrum of the E 1Π-X 1Σ+ Transition of CO.

Gunthardt CE, Wallace CJ, Hall GE, Field RW, North SW.

J Phys Chem A. 2019 Apr 4;123(13):2780-2788. doi: 10.1021/acs.jpca.9b00109. Epub 2019 Mar 13.

PMID:
30811199
19.

The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.

Bjarnason GA, Knox JJ, Kollmannsberger CK, Soulieres D, Ernst DS, Zalewski P, Canil CM, Winquist E, Hotte SJ, North SA, Heng DYC, Macfarlane RJ, Venner PM, Kapoor A, Hansen AR, Eigl BJ, Czaykowski P, Boyd B, Wang L, Basappa NS.

Eur J Cancer. 2019 Feb;108:69-77. doi: 10.1016/j.ejca.2018.12.006. Epub 2019 Jan 14.

20.

Characterization of longitudinal canal tissue in the acorn barnacle Amphibalanus amphitrite.

Wang C, Schultzhaus JN, Taitt CR, Leary DH, Shriver-Lake LC, Snellings D, Sturiale S, North SH, Orihuela B, Rittschof D, Wahl KJ, Spillmann CM.

PLoS One. 2018 Dec 10;13(12):e0208352. doi: 10.1371/journal.pone.0208352. eCollection 2018.

21.

Interprofessional Approach to the Sustained Reduction in Ventilator-Associated Pneumonia in a Pediatric Intensive Care Unit.

McBeth CL, Montes RS, Powne A, North SE, Natale JE.

Crit Care Nurse. 2018 Dec;38(6):36-45. doi: 10.4037/ccn2018121.

PMID:
30504496
22.

Radiotherapy and pasireotide treatment of a growth hormone producing pituitary tumor in a diabetic dog.

Zublena F, Tamborini A, Mooney CT, North SM, Lobacz MA, Andrew D, Woolhead V, Covey H, Schmid HA, Church DB, Niessen SJM.

Can Vet J. 2018 Oct;59(10):1089-1093.

23.

Non-statistical intermolecular energy transfer from vibrationally excited benzene in a mixed nitrogen-benzene bath.

Paul AK, West NA, Winner JD, Bowersox RDW, North SW, Hase WL.

J Chem Phys. 2018 Oct 7;149(13):134101. doi: 10.1063/1.5043139.

24.

Nascent O2 (a 1Δg, v = 0, 1) rotational distributions from the photodissociation of jet-cooled O3 in the Hartley band.

Warter ML, Gunthardt CE, Wei W, McBane GC, North SW.

J Chem Phys. 2018 Oct 7;149(13):134309. doi: 10.1063/1.5051540.

PMID:
30292221
25.

Students' Knowledge and Self-Perceptions Regarding Integrative Medicine and Health Following Training in First-Year Graduate PA, PT, and OT Programs.

North S, Beck B, Liveris M, Vega A, Boyington N, Stockwell L, St George TE, Hopp J.

J Allied Health. 2018 Fall;47(3):e91-e95.

PMID:
30194837
26.

Implementation Strategies for Telestroke: A Qualitative Study of Telestroke Networks in North Carolina.

Shea CM, Turner K, Alishahi Tabriz A, North S.

Telemed J E Health. 2019 Aug;25(8):708-716. doi: 10.1089/tmj.2018.0131. Epub 2018 Sep 7.

PMID:
30192206
27.

Photoactivable Glycolipid Antigens Generate Stable Conjugates with CD1d for Invariant Natural Killer T Cell Activation.

Veerapen N, Kharkwal SS, Jervis P, Bhowruth V, Besra AK, North SJ, Haslam SM, Dell A, Hobrath J, Quaid PJ, Moynihan PJ, Cox LR, Kharkwal H, Zauderer M, Besra GS, Porcelli SA.

Bioconjug Chem. 2018 Sep 19;29(9):3161-3173. doi: 10.1021/acs.bioconjchem.8b00484. Epub 2018 Aug 23.

28.

Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer.

Shivji A, Ali R, North S, Sawyer M, Ghosh S, Chambers C.

J Oncol Pharm Pract. 2019 Sep;25(6):1293-1300. doi: 10.1177/1078155218784716. Epub 2018 Jun 27.

PMID:
29945535
29.

High nutrition risk related to dietary intake is associated with an increased risk of hospitalisation and mortality for older Māori: LiLACS NZ.

North SM, Wham CA, Teh R, Moyes SA, Rolleston A, Kerse N.

Aust N Z J Public Health. 2018 Aug;42(4):375-381. doi: 10.1111/1753-6405.12793. Epub 2018 Jun 11.

PMID:
29888831
30.

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.

Vasdev N, Zargar H, Noël JP, Veeratterapillay R, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Gandhi NM, Griffin J, Montgomery JS, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Sridhar SS, McGrath JS, Aning J, Shariat SF, Wright JL, Morgan TM, Bivalacqua TJ, North S, Barocas DA, Lotan Y, Grivas P, Stephenson AJ, Shah JB, van Rhijn BW, Daneshmand S, Spiess PE, Holzbeierlein JM, Thorpe A, Black PC.

World J Urol. 2019 Jan;37(1):165-172. doi: 10.1007/s00345-018-2361-0. Epub 2018 Jun 7.

PMID:
29882105
31.

Telestroke Adoption Among Community Hospitals in North Carolina: A Cross-Sectional Study.

Shea CM, Tabriz AA, Turner K, North S, Reiter KL.

J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2411-2417. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.032. Epub 2018 May 18.

32.

Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors.

Adams SC, DeLorey DS, Davenport MH, Fairey AS, North S, Courneya KS.

Br J Cancer. 2018 May;118(10):1313-1321. doi: 10.1038/s41416-018-0044-7. Epub 2018 May 8.

33.

The Prognostic Role of the Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer: A Retrospective, Multi-Institutional Study.

Kaiser J, Li H, North SA, Leibowitz-Amit R, Seah JA, Morshed N, Chau C, Lee-Ying R, Heng DYC, Sridhar S, Crabb SJ, Alimohamed NS.

Bladder Cancer. 2018 Apr 26;4(2):185-194. doi: 10.3233/BLC-170133.

34.

Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.

Kassouf W, Aprikian A, Saad F, Breau RH, Kulkarni G, Guttman DM, Bagshaw K, Izawa J, Eapen L, Fairey A, So A, North S, Rendon R, Sridhar SS, Brimo F, Chung P, Drachenberg D, Fradet Y, Jacobsen N, Morash C, Shayegan B, Gotto G, Zlotta A, Fleshner N, Siemens DR, Black PC.

Can Urol Assoc J. 2018 Jul;12(7):E281-E297. doi: 10.5489/cuaj.5246. Epub 2018 Mar 19. No abstract available.

35.

A randomized phase II study of pelareorep and docetaxel or docetaxel alone in men with metastatic castration resistant prostate cancer: CCTG study IND 209.

Eigl BJ, Chi K, Tu D, Hotte SJ, Winquist E, Booth CM, Canil C, Potvin K, Gregg R, North S, Zulfiqar M, Ellard S, Ruether JD, Le L, Kakumanu AS, Salim M, Allan AL, Feilotter H, Theis A, Seymour L.

Oncotarget. 2018 Jan 17;9(8):8155-8164. doi: 10.18632/oncotarget.24263. eCollection 2018 Jan 30.

36.

Arthropods dataset from different genetically modified maize events and associated controls.

Pálinkás Z, Zalai M, Szénási Á, Dorner Z, Kiss J, North S, Woodward G, Balog A.

Sci Data. 2018 Feb 20;5:180019. doi: 10.1038/sdata.2018.19.

37.

BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.

Biswas K, Philip S, Yadav A, Martin BK, Burkett S, Singh V, Babbar A, North SL, Chang S, Sharan SK.

Nat Commun. 2018 Feb 7;9(1):537. doi: 10.1038/s41467-018-03020-6.

38.

Real-world Outcomes in Advanced Urothelial Cancer and the Role of Neutrophil to Lymphocyte Ratio.

Yip SM, Kaiser J, Li H, North S, Heng DYC, Alimohamed NS.

Clin Genitourin Cancer. 2018 Jun;16(3):e637-e644. doi: 10.1016/j.clgc.2017.12.009. Epub 2017 Dec 29.

PMID:
29395946
39.

Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.

Reaume MN, Basappa NS, Wood L, Kapoor A, Bjarnason GA, Blais N, Breau RH, Canil C, Cheung P, Conter HJ, Hotte SJ, Jeldres C, Jewett MAS, Karakiewicz PI, Kollmannsberger C, Patenaude F, So A, Soulières D, Venner P, Violette P, Zalewski P, Chappell H, North SA; Kidney Cancer Research Network of Canada.

Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769. No abstract available.

40.

Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary Malignancies.

Wong SE, North SA, Sweeney CJ, Stockler MR, Sridhar SS.

Clin Genitourin Cancer. 2017 Sep 8. pii: S1558-7673(17)30274-4. doi: 10.1016/j.clgc.2017.08.019. [Epub ahead of print]

PMID:
28993132
41.

PAs: Fifty years young.

Mandel ED, North S.

JAAPA. 2017 Oct;30(10):43-45. doi: 10.1097/01.JAA.0000524714.17719.06. Review.

PMID:
28953023
42.

American Telemedicine Association Practice Guidelines for Telemental Health with Children and Adolescents.

Myers K, Nelson EL, Rabinowitz T, Hilty D, Baker D, Barnwell SS, Boyce G, Bufka LF, Cain S, Chui L, Comer JS, Cradock C, Goldstein F, Johnston B, Krupinski E, Lo K, Luxton DD, McSwain SD, McWilliams J, North S, Ostrowsky J, Pignatiello A, Roth D, Shore J, Turvey C, Varrell JR, Wright S, Bernard J.

Telemed J E Health. 2017 Oct;23(10):779-804. doi: 10.1089/tmj.2017.0177. Epub 2017 Sep 20. No abstract available.

PMID:
28930496
43.

Urban-Rural Differences in School Nurses' Asthma Training Needs and Access to Asthma Resources.

Carpenter DM, Estrada RD, Roberts CA, Elio A, Prendergast M, Durbin K, Jones GC, North S.

J Pediatr Nurs. 2017 Sep - Oct;36:157-162. doi: 10.1016/j.pedn.2017.06.013. Epub 2017 Jun 23.

44.

American Telemedicine Association Operating Procedures for Pediatric Telehealth.

McSwain SD, Bernard J, Burke BL Jr, Cole SL, Dharmar M, Hall-Barrow J, Herendeen N, Herendeen P, Krupinski EA, Martin A, McCafferty D, Mulligan DA, North S, Ruschman J, Waller M, Webster K, Williams S, Yamamoto S, Yeager B.

Telemed J E Health. 2017 Sep;23(9):699-706. doi: 10.1089/tmj.2017.0176. Epub 2017 Aug 22. No abstract available.

PMID:
28829680
45.

Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).

Lavallée LT, Fitzpatrick R, Wood LA, Basiuk J, Knee C, Cnossen S, Mallick R, Witiuk K, Vanhuyse M, Tanguay S, Finelli A, Jewett MAS, Basappa N, Lattouf JB, Gotto GT, Al-Asaaed S, Bjarnason GA, Moore R, North S, Canil C, Pouliot F, Soulières D, Castonguay V, Kassouf W, Cagiannos I, Morash C, Breau RH.

J Cancer Educ. 2019 Feb;34(1):14-18. doi: 10.1007/s13187-017-1259-7.

PMID:
28779441
46.

Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.

Vandekerkhove G, Todenhöfer T, Annala M, Struss WJ, Wong A, Beja K, Ritch E, Brahmbhatt S, Volik SV, Hennenlotter J, Nykter M, Chi KN, North S, Stenzl A, Collins CC, Eigl BJ, Black PC, Wyatt AW.

Clin Cancer Res. 2017 Nov 1;23(21):6487-6497. doi: 10.1158/1078-0432.CCR-17-1140. Epub 2017 Jul 31.

47.

Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial.

Adams SC, DeLorey DS, Davenport MH, Stickland MK, Fairey AS, North S, Szczotka A, Courneya KS.

Cancer. 2017 Oct 15;123(20):4057-4065. doi: 10.1002/cncr.30859. Epub 2017 Jul 14.

48.

A method of extracting speed-dependent vector correlations from 2 + 1 REMPI ion images.

Wei W, Wallace CJ, Grubb MP, North SW.

J Chem Phys. 2017 Jul 7;147(1):013947. doi: 10.1063/1.4985704.

PMID:
28688436
49.

The role of the built environment in a randomized controlled trial to increase physical activity among men with prostate cancer: the PROMOTE trial.

McGowan EL, Fuller D, Cutumisu N, North S, Courneya KS.

Support Care Cancer. 2017 Oct;25(10):2993-2996. doi: 10.1007/s00520-017-3798-1. Epub 2017 Jun 27.

PMID:
28656468
50.

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.

Antonarakis ES, Tagawa ST, Galletti G, Worroll D, Ballman K, Vanhuyse M, Sonpavde G, North S, Albany C, Tsao CK, Stewart J, Zaher A, Szatrowski T, Zhou W, Gjyrezi A, Tasaki S, Portella L, Bai Y, Lannin TB, Suri S, Gruber CN, Pratt ED, Kirby BJ, Eisenberger MA, Nanus DM, Saad F, Giannakakou P; TAXYNERGY Investigators.

J Clin Oncol. 2017 Oct 1;35(28):3181-3188. doi: 10.1200/JCO.2017.72.4138. Epub 2017 Jun 20.

Supplemental Content

Support Center